Verdun

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria3 trials
• Atopic dermatitis (eczema)1 trial
• Psoriasis1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Recruiting

  Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

  NCT06947993· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Recruiting

  Modifying PEST for Psoriatic Arthritis Screening

  NCT06382051· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

  NCT06042478· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

  NCT05513001· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting

Closed trials

• Completed

  A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

  NCT05032157· Phase 3· Novartis Pharmaceuticals· Source